VF
LSTA icon

Virtu Financial’s Lisata Therapeutics LSTA Stock Holding History

Virtu Financial’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$211K Buy
+42,213
New +$174K 0.01% 1003
2022
Q1 		– Sell
-10,684
Closed -$135K – 1791
2021
Q4 		$135K Buy
+10,684
New +$165K 0.01% 997
2021
Q1 		– Sell
-3,507
Closed -$75K – 1842
2020
Q4 		$75K Buy
+3,507
New +$83.2K 0.01% 1135
2019
Q3 		– Sell
-775
Closed -$26K – 1652
2019
Q2 		$26K Buy
+775
New +$34.4K ﹤0.01% 1315

Other funds holding LSTA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

Virtu Financial's LSTA Position: Q1 2026 in Review

Virtu Financial opened a new position in Lisata Therapeutics (LSTA) in Q1 2026: 42,213 shares worth $211K. The stake represents 0.01% of the portfolio and ranks #1003 among its holdings. This is a return to the name: Virtu Financial previously reported a position in LSTA as recently as Q4 2021.

Virtu Financial first reported a position in LSTA in Q2 2019 and has held it in 4 quarters since. 34 funds tracked by Wall St. Rank hold LSTA as of Q1 2026.

  • Virtu Financial held 42,213 shares of Lisata Therapeutics worth $211K as of Q1 2026.
  • Lisata Therapeutics was a new Virtu Financial position in Q1 2026.
  • Lisata Therapeutics made up 0.01% of Virtu Financial's portfolio in Q1 2026, its #1003 holding.
  • Virtu Financial first reported a position in Lisata Therapeutics in Q2 2019 and has held it in 4 quarters since.
  • 34 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.